Genentech To Collaborate With ABC2 For Brain Cancer Research

Biotech Company and Non-Profit Foundation Join Forces

26-Feb-2002

BURLINGAME, CA and SOUTH SAN FRANCISCO, CA -- February 25, 2002 -- Accelerate brain cancer Cure (ABC2), a non-profit foundation created by the Dan and Steve Case families, and Genentech, Inc. (NYSE:DNA) today announced a collaboration to develop new therapies specifically designed to treat patients with brain cancer. This collaboration represents the first of a series of collaborations for ABC2 based on a new model of partnering between ABC2 and the bio-pharmaceutical industry to rapidly move new therapies into the clinic to benefit patients with this disease.

Under the collaboration, ABC2 will share development expenses with Genentech and provide access to its resources, including relationships with leading researchers and clinicians. Genentech will contribute its world-renowned experience in designing and developing pioneering therapeutics to the venture. Genentech would commercialize any resulting products and ABC2 would receive a royalty on product sales.

"Today's announcement represents a revolutionary new model for us to work with the biotechnology and pharmaceutical industries to advance the search for a cure for this devastating disease," said Steve Case, chairman of AOL/Time Warner, and chairman of ABC2. "This is just the first of a series of collaborations that ABC2 will announce which we believe will significantly improve the prospects for the treatment of brain cancer."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures
View topic world

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures